1. Home
  2. AXG vs IPSC Comparison

AXG vs IPSC Comparison

Compare AXG & IPSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Solowin Holdings Class A Ordinary Share

AXG

Solowin Holdings Class A Ordinary Share

HOLD

Current Price

$2.10

Market Cap

440.3M

Sector

Finance

ML Signal

HOLD

Logo Century Therapeutics Inc.

IPSC

Century Therapeutics Inc.

N/A

Current Price

$1.97

Market Cap

362.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AXG
IPSC
Founded
2021
2019
Country
Hong Kong
United States
Employees
N/A
N/A
Industry
Investment Bankers/Brokers/Service
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
440.3M
362.5M
IPO Year
2022
2021

Fundamental Metrics

Financial Performance
Metric
AXG
IPSC
Price
$2.10
$1.97
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$4.25
AVG Volume (30 Days)
96.8K
386.4K
Earning Date
01-09-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
91.30
EPS
N/A
N/A
Revenue
N/A
$109,164,000.00
Revenue This Year
$28.53
N/A
Revenue Next Year
$54.60
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
1556.76
52 Week Low
$1.90
$0.44
52 Week High
$4.75
$2.97

Technical Indicators

Market Signals
Indicator
AXG
IPSC
Relative Strength Index (RSI) N/A N/A
Support Level N/A N/A
Resistance Level N/A N/A
Average True Range (ATR) 0.00 0.00
MACD 0.00 0.00
Stochastic Oscillator 0.00 0.00

Price Performance

Historical Comparison
AXG
IPSC

About AXG Solowin Holdings Class A Ordinary Share

Solowin Holdings Ltd is an investor-focused, versatile securities brokerage company in Hong Kong. It offers a wide spectrum of products and services through its secure one-stop electronic platform. It is engaged in providing securities-related services, investment advisory services, and asset management services to customers. The operations were organized into four reportable segments: Digital Asset Tokens, and AI Tokens. It generates maximum revenue from AI Tokens segment.

About IPSC Century Therapeutics Inc.

Century Therapeutics Inc is a biotechnology company harnessing the power of allogeneic pluripotent stem cell therapies to develop potentially curative cell therapy products for autoimmune diseases, including type 1 diabetes, or T1D, and cancer. Its beta islet, T cell and NK cell programs are allogeneic, meaning it is derived from healthy donors for use in any patient, rather than being sourced from an individual for their own specific use, as is the case with autologous T cells. The cell types it can generate from iPSCs, including iPSC-derived beta islet cells, iPSC-derived CD4+ and CD8+ alphabeta T cells, or alphabeta iT cells, and iPSC- natural killer cells, or iNK cells.

Share on Social Networks: